The Chairman of Kabaka Mutebi’s Buganda Civic Education Committee and leading Muganda radio personality, Betty Nambooze Bakireke, is expected to return home from South Africa today. Nambooze went to South Africa for emergency medical treatment three weeks ago after serious efforts by the NRM occupation government to deny her quality medical treatment (see “Museveni Commits Crimes Against Humanity, Denies Nambooze Medical Care”).

According to family sources, Ms. Nambooze is feeling much better after undergoing extensive medical testing and receiving treatment to stabilize her condition. She is also well rested and stronger. Madam Tica (Teacher), as Nambooze is popularly known to her fans, is expected to return to South Africa very early next year to undergo surgery in the abdominal area.

According to Betty Nambooze, her medical problems were created by Mr. Museveni’s occupation government and its operatives. For several years now, Betty Nambooze has told her CBS FM radio listeners that when she was arrested in Mukono for opposing land grabbing by Juma Seiko, the police forcibly injected her with a strange chemical. Juma Seiko is an army man who doubles as an aide to Museveni’s half brother, Caleb Akandwanaho (Salim Saleh). Then, in 2007, Museven’s NRM government kidnapped Nambooze for nearly a week shortly after she had given birth by C-section. The wound ruptured as Ms. Nambooze was in captivity, leading to long term complications. Also kidnapped were Buganda ministers Lubega Sseggona and Peter Mayiga. The man in charge of the kidnap operations was a Mulaalo named David Tinyefuza.

On CBS FM radio, Nambooze enjoyed a radio an estimated audience of 5 million listeners. However, as of Monday evening, no major public welcome event that matches Nambooze’s popularity had been announced. In the meantime, police sources have revealed that the Rwandese command of the Uganda occupation police, Karyekeezi Kayihura, has prepared a force of a few hundred men on standby to crush any Baganda demonstrations.

According to a Boston based improvised radio station, using multimedia SMS messages to broadcast, Kabaka Mutebi will shortly travel to South Africa on November 10, 2009, to visit his subject Betty Nambooze. The SMS broadcast, which one of our readers downloaded and emailed to us, carries the “Ekiba Kibe Program”, presented by Robert Kabuye. In a charismatic brave voice Kabuye first announces that Betty Nambooze is in terrible medical shape and appears to face certain death. Apparently, because “her intestines fast disintegrating.” Kabuye repeats what Nambooze has said for years now, that Museveni’s security people injected her with some suspicious chemical when she was in police custody.

Also in the SMS Kabuye, who keeps saying “Museveni must go” throughout his broadcast, claims that Kabaka Ronald Muwenda Mutebi will travel to South Africa on Tuesday this week, to visit Betty Nambooze Bakireke. We have not been able to independently confirm if Nambooze is facing certain death or whether Ssabasajja will indeed travel as Mr. Kabuye says. Click on this link Ekibakibe_09Sep09A.wav to listen to Mr. Kabuye.

Mr. Kabuye has made himself a name as a very effective communicator, who has mastered the multi-media SMS technology. His messages get to hundreds of Bagadna phones in the USA, Europe, Uganda and other countries. Sources also tell us that Mr. Kabuye is a very strong supporter of Frank Musisi, the former UNAA president. Indeed he intially started his SMS radio to campaign for Musisi when he was running for UNAA president. The same sources tell us that Mr. Kabuye’s energy and excellent communication skills also did a lot to get over 300 to attended the recent Emergency Buganda  Conference, organized by John Mayanja (see “Resolutions of the Buganda Emergency Meeting in Boston on October 17, 2009‏”).

In another related story, the people of Buganda were gripped by anxiety, anger and despair over the weekend after rumors spread by text messages that Betty Nambooze had died. Our source in Kayembe, near Nakasero market, told this writer: “The situation was tense and we feared that if the rumors got confirmed, anything could explode. The problem is that one could not tell where the rumor started. And because of the CBS Radio shut down we did not know who to listen to. Now, we have gotten to know that in fact the rumor was intentionally spread by ISO on instructions from Museveni’s statehouse.”

Below is a statement from Global HIV Vaccine Enterprise executive director, Dr. Alan Bernstein.  The Enterprise (http://www.hivvaccineenterprise.org) is a global alliance of researchers, funders, policy makers and advocates that includes the African AIDS Vaccine Program, the AIDS Vaccine Advocacy Coalition (AVAC), the AIDS Vaccine Asian Network, the Bill & Melinda Gates Foundation, the Canadian HIV Vaccine Initiative, the Center for HIV/AIDS Vaccine Immunology, the Chinese AIDS Vaccine Initiative, the Collaboration for AIDS Vaccine Discovery (CAVD), the Department for International Development, the European Commission, Europrise, Eurovacc, GlaxoSmithKline, the HIV Vaccine Trials Network (HVTN), the International AIDS Vaccine Initiative (IAVI), Merck & Co. Inc., the National Agency for AIDS Research (ANRS), the National Institute of Allergy and Infectious Diseases (NIAID), Novartis Vaccines, sanofi pasteur, the South African AIDS Vaccine Initiative (SAAVI), the U.S. Military HIV Research Program (MHRP), UNAIDS, USAID, Vaccine Research Center (VRC), Wellcome Trust and the World Health Organization (WHO).

Dr. Bernstein is available to speak with journalists to help put the Thai trial results into perspective and to comment on their significance for the future of HIV vaccine research.  To interview Dr. Bernstein, please contact Mark Aurigemma at (212) 600-1960, (646) 270-9451 or mark@aucomm.net; or Jennifer Brunet at (212) 46i-3693 or jbrunet@vaccineenterprise.org.

“This is a historic day in the 26-year quest to develop an AIDS vaccine.  The results of the Thai Phase III HIV vaccine clinical trial of the “prime-boost” combination of ALVAC-HIV vaccine and AIDSVAC B/E vaccine demonstrate that a safe and effective AIDS vaccine is an achievable goal. This trial is the first demonstration in humans that, with more research, it will be possible to develop a vaccine that is fully protective against HIV.

These results represent the most significant advance in HIV vaccine research to date, and a ray of hope for the more than 2.7 million women, men and children who become newly infected with HIV every year across the globe.  Current prevention efforts can lower HIV risk, but a safe and effective vaccine will be essential to ending this epidemic.

We owe an enormous debt of thanks to the people of Thailand, and especially to the more than 16,000 women and men who selflessly participated in this clinical trial. This significant scientific milestone – the first vaccine study to reduce HIV infections in humans – would not have been reached without their engagement and the efforts of the trial sponsors – Enterprise stakeholders including the U.S. Military HIV Research Program (MHRP), the U.S. National Institute of Allergy and Infectious Diseases (NIAID), and sanofi pasteur – as well as the Thailand Ministry of Public Health and Global Solutions for Infectious Diseases (GSID).

The reduction in HIV infection risk measured in this study, 31.2 percent, was modest, but raises important implications for future research directions. HIV vaccine researchers, funders and advocates must now continue to work together, as quickly and effectively as possible, to understand why this vaccine regimen worked as it did, how its efficacy can be improved, whether and how it may work in other parts of the world, and how to develop new vaccine candidates that expand on the level of protection achieved here.

This study also demonstrates the importance of global cooperation and collaboration – the central values of the Global HIV Vaccine Enterprise – in accelerating the search for a safe and effective HIV vaccine.  Researchers, advocates, funders and policy makers are working together through the Global HIV Vaccine Enterprise process to develop and test new vaccine candidates. Full data from the Thai trial will be presented at the Enterprise’s annual scientific conference, AIDS Vaccine 2009, in Paris on October 19-22. http://www.hivvaccineenterprise.org/conference/2009/

Finally, these results are an immediate call to action to governments, funders, policy makers, researchers and advocates to dramatically step up our efforts to develop and make globally available a safe and effective HIV vaccine. Stakeholders of the Global HIV Vaccine Enterprise will continue to lead this fight, but developing a safe and effective AIDS vaccine will require the full and collective efforts of every individual and organization worldwide committed to ending this devastating epidemic.

Global HIV Vaccine Enterprise partners will be working aggressively in the months ahead to address the many scientific questions raised by this study, and to develop and test other vaccine candidates.  The findings of this trial will also help inform strategies outlined in the updated Enterprise Scientific Strategic Plan, the global strategy for HIV vaccine research currently being developed by over 150 scientists from around the world, to be released in spring 2010.

We look forward to hosting the ongoing discussion of results of this trial and the discussion of next steps in the journey to find an AIDS vaccine at the AIDS Vaccine 2009 conference in Paris, October 19-22.

The Uganda Cricket team put up a valiant fight on April 6, 2009 against the current ICC Cricket World Cup Qualifier Champions, Scotland.

The match at Wits University, Johannesburg, South Africa ended with Scotland ahead by 45 runs despite valiant batting performances – in particular that of captain, Junior Kwebiha, eventually caught by Scotland’s Moneeb Iqbal after making 69 runs – and the collapse of the Scottish batters in the last 3 overs of the 1st innings. Ronald Mukasa also put in a fine batting performance with 6 boundaries, finishing on 37 runs after being bowled by Dewald Nel.

Uganda finished all out for 164, against Scotland’s first innings total of 209 for 9.

This was the 4th match in the group that includes Ireland, Canada, Namibia and Oman. Uganda’s next game will be on Wednesday, April 8, 2009 against Oman in Pretoria. The Super8 leg of the tournament will begin on Saturday ,  April 11, 2009 but it is yet to be seen if Uganda will make it through or if the 4th place in Group A will go to Oman.

Sally Jacobs in Johannesburg for Buganda Post